IgA-specific proteins of pathogenic bacteria
暂无分享,去创建一个
[1] F. Lowy. Staphylococcus aureus infections. , 2009, The New England journal of medicine.
[2] J. Fraser,et al. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1 , 2007, Proceedings of the National Academy of Sciences.
[3] A. Shevelev,et al. Unknown functions of immunoglobulins A , 2007, Biochemistry (Moscow).
[4] Manisha Pandey,et al. Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease , 2006, Immunologic research.
[5] K. Drasbek,et al. Horizontal transfer of the immunoglobulin A1 protease gene (iga) from Streptococcus to Gemella haemolysans. , 2006, Microbiology.
[6] I. André,et al. Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. , 2006, Biochemistry.
[7] H. Mckenzie,et al. Molecular epidemiology of macrolide resistance in beta-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). , 2006, The Journal of antimicrobial chemotherapy.
[8] M. Inoue,et al. Genetic diversity of the C protein beta-antigen gene and its upstream regions within clonally related groups of type Ia and Ib group B streptococci. , 2006, Microbiology.
[9] G. Ball,et al. Human C4b-binding Protein, Structural Basis for Interaction with Streptococcal M Protein, a Major Bacterial Virulence Factor* , 2006, Journal of Biological Chemistry.
[10] John D. Fraser,et al. A Competitive Mechanism for Staphylococcal Toxin SSL7 Inhibiting the Leukocyte IgA Receptor, FcαRI, Is Revealed by SSL7 Binding at the Cα2/Cα3 Interface of IgA* , 2006, Journal of Biological Chemistry.
[11] Fredric Carlsson,et al. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non‐opsonic epitopes , 2006, Molecular microbiology.
[12] J. McArthur,et al. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development , 2006, Molecular microbiology.
[13] D. Filman,et al. Crystal Structure of the N-terminal Domain of the Group B Streptococcus Alpha C Protein* , 2005, Journal of Biological Chemistry.
[14] G. Lindahl,et al. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway , 2005, Molecular microbiology.
[15] John D. Fraser,et al. The Staphylococcal Superantigen-Like Protein 7 Binds IgA and Complement C5 and Inhibits IgA-FcαRI Binding and Serum Killing of Bacteria1 , 2005, The Journal of Immunology.
[16] G. Lindahl,et al. Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens , 2005, Clinical Microbiology Reviews.
[17] D. Pérez-Caballero,et al. Interaction between Complement Regulators and Streptococcus pyogenes: Binding of C4b-Binding Protein and Factor H/Factor H-Like Protein 1 to M18 Strains Involves Two Different Cell Surface Molecules1 , 2004, The Journal of Immunology.
[18] K. Berggård,et al. Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein , 2003, The Journal of experimental medicine.
[19] S. Meri,et al. Complement resistance mechanisms of streptococci. , 2003, Molecular immunology.
[20] J. Woof. The human IgA-Fc α receptor interaction and its blockade by streptococcal IgA-binding proteins , 2002 .
[21] G. Lindahl,et al. Isolation and Detection of Human IgA Using a Streptococcal IgA-Binding Peptide1 , 2002, The Journal of Immunology.
[22] D. Kasper,et al. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. , 2002, The Journal of infectious diseases.
[23] F. Kong,et al. Molecular Profiles of Group B Streptococcal Surface Protein Antigen Genes: Relationship to Molecular Serotypes , 2002, Journal of Clinical Microbiology.
[24] E. Lindahl,et al. Isolated Hypervariable Regions Derived from Streptococcal M Proteins Specifically Bind Human C4b-Binding Protein: Implications for Antigenic Variation1 , 2001, The Journal of Immunology.
[25] K. Berggård,et al. Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes , 2001, Molecular microbiology.
[26] L. Truedsson,et al. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H‐like protein 1 binding , 2001, Molecular microbiology.
[27] E. van Garderen,et al. IgA and the IgA Fc receptor. , 2001, Trends in immunology.
[28] G. Lindahl,et al. Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89* , 2001, The Journal of Biological Chemistry.
[29] J. Ward,et al. Identification of a Novel Gene Cluster Encoding Staphylococcal Exotoxin-Like Proteins: Characterization of the Prototypic Gene and Its Protein Product, SET1 , 2000, Infection and Immunity.
[30] J. Orenstein,et al. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. , 1999, The Journal of clinical investigation.
[31] J. Dunlop,et al. Identification of Residues in the CH2/CH3 Domain Interface of IgA Essential for Interaction with the Human Fcα Receptor (FcαR) CD89* , 1999, The Journal of Biological Chemistry.
[32] E. Johnsson,et al. An IgA-binding Peptide Derived from a Streptococcal Surface Protein* , 1999, The Journal of Biological Chemistry.
[33] L. Björck,et al. Protein H, an Antiphagocytic Surface Protein inStreptococcus pyogenes , 1999, Infection and Immunity.
[34] William Wiley Navarre,et al. Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.
[35] K. Berggård,et al. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. , 1998, Journal of immunology.
[36] R. Dwek,et al. The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* , 1998, The Journal of Biological Chemistry.
[37] T. Cedervall,et al. Coiled-coil structure of group A streptococcal M proteins. Different temperature stability of class A and C proteins by hydrophobic-nonhydrophobic amino acid substitutions at heptad positions a and d. , 1997, Biochemistry.
[38] M. Pangburn,et al. Localization by site-directed mutagenesis of the site in human complement factor H that binds to Streptococcus pyogenes M protein , 1997, Infection and immunity.
[39] K. Timmis,et al. Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci , 1996, Infection and immunity.
[40] W. Müller-Esterl,et al. Identification of a plasminogen‐binding motif in PAM, a bacterial surface protein , 1995, Molecular microbiology.
[41] G. Lindahl,et al. Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes , 1995, Infection and immunity.
[42] E. Johnsson,et al. Identification of the IgA-binding region in streptococcal protein Arp. , 1994, Journal of immunology.
[43] G. Lindahl,et al. Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. , 1994, The Journal of biological chemistry.
[44] D. Bessen,et al. Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci , 1994, Infection and immunity.
[45] G. Lindahl,et al. Two major classes in the M protein family in group A streptococci. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Robinson,et al. Group A streptococcal M proteins: virulence factors and protective antigens. , 1992, Immunology today.
[47] L. Björck,et al. Protein Arp and protein H from group A streptococci. Ig binding and dimerization are regulated by temperature. , 1992, Journal of immunology.
[48] G. Lindahl,et al. Many group A streptococcal strains express two different immunoglobulin‐binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M‐type , 1992, Molecular microbiology.
[49] M. Kehoe. Group A streptococcal antigens and vaccine potential. , 1991, Vaccine.
[50] G. Lindahl,et al. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline‐rich region with unique structure and isolation of N‐terminal fragments with IgA‐binding capacity , 1991, European journal of immunology.
[51] V. Fischetti,et al. Streptococcal M protein. , 1991, Scientific American.
[52] G. Lindahl,et al. Binding properties of protein Arp, a bacterial IgA-receptor. , 1991, Molecular immunology.
[53] G. S. Chhatwal,et al. The IgA‐binding β antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions , 1991, Molecular microbiology.
[54] M. Kerr,et al. The structure and function of human IgA. , 1990, The Biochemical journal.
[55] G. Lindahl,et al. Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci , 1990, Epidemiology and Infection.
[56] G. Lindahl,et al. Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli , 1989, Molecular microbiology.
[57] K. Kobayashi,et al. Complexes of albumin and alpha 1-antitrypsin with Fc-fragment of IgA monomer are disulfide-bound to penultimate C-terminal cysteine in the C alpha 3-domain. , 1987, Immunology letters.
[58] E. Méndez,et al. The molecular organization of the protein HC-IgA complex (HC-IgA). , 1986, The Journal of biological chemistry.
[59] H. Nohynek. Diagnosis and prevention of pneumococcal disease. , 2006, Advances in experimental medicine and biology.
[60] N. Nagano,et al. High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci. , 2002, Infection and immunity.
[61] Paul M. Orwin,et al. Exotoxins of Staphylococcus aureus. , 2000, Clinical microbiology reviews.
[62] J. Dale. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. , 1999, Vaccine.